Our research centers on deciphering the molecular mechanisms controlling antitumor immunity, and exploiting knowledge to device new gene- and cell-based cancer immunotherapies.
We have two active research directions:
Dr. Lili Yang receives the Outstanding New Investigator Award from the American Society of Gene & Cell Therapy (ASGCT). [PDF][Link]
Dr. Lili Yang receives a $7.6M CIRM 2.0 Partnering Opportunity for Translational Research Projects Award to translate a new stem cell-based immunotherapy